3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Metabolically healthy obese and metabolic syndrome of the lean: the importance of diet quality. Analysis of MAGNETIC cohort

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Obesity is considered as an indispensable component of metabolic health assessment and metabolic syndrome diagnosis. The associations between diet quality and metabolic health in lean, young adults have not been yet established whilst data addressing this issue in overweight and obese subjects is scarce. Our analysis aimed to establish the link between diet quality (measured with data-driven dietary patterns and diet quality scores) and metabolic syndrome (MS) in young adults, regardless of their adiposity status.

          Methods

          A total of 797 participants aged 18–35 years old were included in the study. Participants were assigned into metabolic syndrome (MS) group if at least two abnormalities within the following parameters were present: blood pressure, triglycerides, total cholesterol, HDL cholesterol, blood glucose. Participants with one or none abnormalities were considered as metabolically healthy subjects (MH), Diet quality was assessed with two approaches: 1) a posteriori by drawing dietary patterns (DPs) with principal component analysis (PCA) and 2) a priori by establishing diet quality scores and the adherence to pro-Healthy-Diet-Index (pHDI) and non-Healthy-Diet-Index (nHDI). Logistic regression with backward selection based on Akaike information criterion was carried out, to identify factors independently associated with metabolic health.

          Results

          Within the MS group, 31% were of normal weight. Three PCA-driven DPs were identified, in total explaining 30.0% of the variance: “Western” (11.8%), “Prudent” (11.2%) and “Dairy, breakfast cereals & treats” (7.0%). In the multivariate models which included PCA-driven DPs, higher adherence to middle and upper tertiles of “Western” DP (Odds Ratios [OR] and 95% Confidence Intervals [95% CI]: 1.72, 1.07–2.79 and 1.74, 1.07–2.84, respectively), was associated with MS independently of clinical characteristics including BMI and waist-hip ratio (WHR). Similar results were obtained in the multivariate model with diet quality scores - MS was independently associated with higher scores within nHDI (2.2, 0.92–5.28).

          Conclusions

          Individuals with MS were more likely to adhere to the western dietary pattern and have a poor diet quality in comparison to metabolically healthy peers, independently of BMI and WHR. It may imply that diet composition, as independent factor, plays a pivotal role in increasing metabolic risk. Professional dietary advice should be offered to all metabolically unhealthy patients, regardless of their body mass status.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

          Visceral adipose tissue (VAT) compartments may confer increased metabolic risk. The incremental utility of measuring both visceral and subcutaneous abdominal adipose tissue (SAT) in association with metabolic risk factors and underlying heritability has not been well described in a population-based setting. Participants (n=3001) were drawn from the Framingham Heart Study (48% women; mean age, 50 years), were free of clinical cardiovascular disease, and underwent multidetector computed tomography assessment of SAT and VAT volumes between 2002 and 2005. Metabolic risk factors were examined in relation to increments of SAT and VAT after multivariable adjustment. Heritability was calculated using variance-components analysis. Among both women and men, SAT and VAT were significantly associated with blood pressure, fasting plasma glucose, triglycerides, and high-density lipoprotein cholesterol and with increased odds of hypertension, impaired fasting glucose, diabetes mellitus, and metabolic syndrome (P range < 0.01). In women, relations between VAT and risk factors were consistently stronger than in men. However, VAT was more strongly correlated with most metabolic risk factors than was SAT. For example, among women and men, both SAT and VAT were associated with increased odds of metabolic syndrome. In women, the odds ratio (OR) of metabolic syndrome per 1-standard deviation increase in VAT (OR, 4.7) was stronger than that for SAT (OR, 3.0; P for difference between SAT and VAT < 0.0001); similar differences were noted for men (OR for VAT, 4.2; OR for SAT, 2.5). Furthermore, VAT but not SAT contributed significantly to risk factor variation after adjustment for body mass index and waist circumference (P < or = 0.01). Among overweight and obese individuals, the prevalence of hypertension, impaired fasting glucose, and metabolic syndrome increased linearly and significantly across increasing VAT quartiles. Heritability values for SAT and VAT were 57% and 36%, respectively. Although both SAT and VAT are correlated with metabolic risk factors, VAT remains more strongly associated with an adverse metabolic risk profile even after accounting for standard anthropometric indexes. Our findings are consistent with the hypothesized role of visceral fat as a unique, pathogenic fat depot. Measurement of VAT may provide a more complete understanding of metabolic risk associated with variation in fat distribution.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The link between abdominal obesity, metabolic syndrome and cardiovascular disease.

            The prevalence of metabolic syndrome has increased dramatically in recent years, and the cluster of metabolic abnormalities it encompasses results in increased cardiovascular morbidity and mortality. The role of abdominal (visceral) obesity and the underlying molecular and cellular mechanisms central to this association have been the subject of intensive research in recent times. The aim of this review is to correlate data in this area, highlighting the central role of excess visceral fat and its secreted adipokines, and to review existing and emerging therapies. Data were generated from a search of the PubMed database using the terms 'abdominal obesity', 'metabolic syndrome', 'insulin resistance', 'adipokines', 'interleukin-6 (IL-6)', 'adiponectin', 'tumour necrosis factor-alpha (TNF-alpha)' and 'cardiovascular disease'. Metabolic syndrome is associated with a pro-inflammatory state, and the role of visceral obesity is thought to be central to this. Visceral obesity leads to alteration of the normal physiological balance of adipokines, insulin resistance, endothelial dysfunction and a pro-atherogenic state. In association with this, the presence of conventional cardiovascular risk factors such as hypertension, dyslipidaemia and smoking results in a significantly elevated cardiovascular and metabolic (cardiometabolic) risk. Better understanding of the molecular mechanisms central to this association has led to the development of potential therapeutic agents.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals.

              The risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (DM) associated with obesity appears to be influenced by the coexistence of other metabolic abnormalities. We examined the risk of developing CVD and DM in metabolically healthy obese (MHO) and metabolically unhealthy normal weight (MUH-NW) individuals. We analyzed prospective data of the San Antonio Heart Study, a population-based study among Mexican Americans and non-Hispanic whites (median follow-up, 7.4 y). Incident DM and CVD were assessed in 2814 and 3700 participants aged 25 to 64 years, respectively. MHO was defined as obesity (body mass index ≥ 30 kg/m(2)) with no more than one metabolic abnormality, and MUH-NW was defined as body mass index <25 kg/m(2) with two or more abnormalities. In logistic regression models, BMI was associated with incident DM after controlling for demographics, family history of DM, and fasting glucose (odds ratio × 1 SD, 1.7 [95% CI, 1.5-2.0]). Both MUH-NW and MHO individuals had an increased DM risk (2.5 [1.1-5.6] and 3.9 [2.0-7.4], respectively). Similarly, BMI was related to incident CVD after adjusting for demographics and Framingham risk score (1.3 [1.1-1.6]). Incident CVD was also increased in MUH-NW and MHO individuals (2.9 [1.3-6.4] and 3.9 [1.9-7.8], respectively). Results were consistent across gender and ethnic categories. The risk of developing DM and CVD is increased in MUH-NW and MHO individuals. Screening for obesity and other metabolic abnormalities should be routinely performed in clinical practice to institute appropriate preventive measures.
                Bookmark

                Author and article information

                Contributors
                kamila.osadnik@onet.pl
                tadeusz.osadnik@sccs.pl
                marta.lonnie@uwm.edu.pl
                mateusz.lejawa@gmail.com
                r.regula@gmail.com
                martynafronczekk@vp.pl
                marcin.gawlita@wp.pl
                lidia.wadolowska@uwm.edu.pl
                m.gasior@op.pl
                n-pawlas@wp.pl
                Journal
                Nutr J
                Nutr J
                Nutrition Journal
                BioMed Central (London )
                1475-2891
                25 February 2020
                25 February 2020
                2020
                : 19
                : 19
                Affiliations
                [1 ]GRID grid.411728.9, ISNI 0000 0001 2198 0923, Department of Pharmacology, Faculty of Medical Sciences in Zabrze, , Medical University of Silesia, ; Jordana 38, 41-808 Zabrze, Poland
                [2 ]GRID grid.419246.c, ISNI 0000 0004 0485 8725, 2nd Department of Cardiology and Angiology, Silesian Center for Heart Diseases, ; Marii Skłodowskiej-Curie 9, 41-800 Zabrze, Poland
                [3 ]GRID grid.412607.6, ISNI 0000 0001 2149 6795, Department of Human Nutrition, Faculty of Food Science, , University of Warmia and Mazury in Olsztyn, ; Słoneczna 45f, 10-718 Olsztyn, Poland
                [4 ]GRID grid.411728.9, ISNI 0000 0001 2198 0923, 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, , Medical University of Silesia, ; Marii Skłodowskiej-Curie 9, 41-800 Zabrze, Poland
                [5 ]GRID grid.411728.9, ISNI 0000 0001 2198 0923, Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, , Medical University of Silesia, ; Jordana 19, 41-808 Zabrze, Poland
                [6 ]GRID grid.411728.9, ISNI 0000 0001 2198 0923, Department of Environmental Medicine and Epidemiology, Faculty of Medical Sciences in Zabrze, , Medical University of Silesia, ; Jordana 19, 41-808 Zabrze, Poland
                Author information
                http://orcid.org/0000-0002-3202-6972
                Article
                532
                10.1186/s12937-020-00532-0
                7041188
                32098622
                23ba674d-c8f4-4e04-9da4-54e68a4a600a
                © The Author(s) 2020

                Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 16 July 2019
                : 11 February 2020
                Funding
                Funded by: National Science Centre
                Award ID: 2014/13/B/NZ5/03166, OPUS 7
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2020

                Nutrition & Dietetics
                dietary patterns,diet quality,metabolic health,metabolic syndrome,principal component analysis,young adults

                Comments

                Comment on this article